These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29661022)

  • 21. Understanding invisible pain in the older adult: a content analysis of social media's representation of herpes zoster vaccine.
    Yang M; Yang Y; Li S
    Front Public Health; 2024; 12():1420349. PubMed ID: 39109157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.
    Marin M; Yawn BP; Hales CM; Wollan PC; Bialek SR; Zhang J; Kurland MJ; Harpaz R
    Hum Vaccin Immunother; 2015; 11(5):1157-64. PubMed ID: 25806911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of a herpes zoster vaccination program among the French elderly people.
    Belchior E; Lévy-Bruhl D; Le Strat Y; Herida M
    Hum Vaccin Immunother; 2016 Sep; 12(9):2378-82. PubMed ID: 27484158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of Herpes Zoster Vaccination Among Inflammatory Bowel Disease Patients.
    Khan N; Trivedi C; Kavani H; Lewis J; Yang YX
    Inflamm Bowel Dis; 2019 Jan; 25(2):345-351. PubMed ID: 29982646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.
    Horn J; Karch A; Damm O; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Hengel H; Greiner W; Mikolajczyk RT
    Hum Vaccin Immunother; 2016 Jul; 12(7):1766-76. PubMed ID: 26835890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of medical and/or pharmacy reimbursement on adult vaccination rates.
    Deshpande G; Visaria J; Singer J; Johnson KD
    Am J Manag Care; 2018 Jul; 24(8 Spec No.):SP286-SP293. PubMed ID: 30020746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes Zoster Vaccine Response in Inflammatory Bowel Disease Patients on Low-dose Immunosuppression.
    Wasan SK; Zullow S; Berg A; Cheifetz AS; Ganley-Leal L; Farraye FA
    Inflamm Bowel Dis; 2016 Jun; 22(6):1391-6. PubMed ID: 27057679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studying physician knowledge, attitudes, and practices regarding the herpes zoster vaccine to address perceived barriers to vaccination.
    Elkin Z; Cohen EJ; Goldberg JD; Gillespie C; Li X; Jung J; Cohen M; Park L; Perskin MH
    Cornea; 2013 Jul; 32(7):976-81. PubMed ID: 23449488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpes zoster vaccination: benefits and barriers.
    Komara FA
    J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S22-4. PubMed ID: 19553633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Pharmacist Interventions on Herpes Zoster Vaccination Rates.
    Eid DD; Meagher RC; Lengel AJ
    Consult Pharm; 2015 Aug; 30(8):459-62. PubMed ID: 26260642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influenza Vaccine Uptake in the Year After Concurrent vs Separate Influenza and Zoster Immunization.
    Rome BN; Feldman WB; Fischer MA; Desai RJ; Avorn J
    JAMA Netw Open; 2021 Nov; 4(11):e2135362. PubMed ID: 34797367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herpes zoster subunit vaccine for the prevention of herpes zoster.
    Symoniak MR; Farrokh P; Gandhi MA; Slish JC
    Am J Health Syst Pharm; 2018 Jun; 75(12):861-869. PubMed ID: 29880523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the potential public health impact of Herpes Zoster vaccination in Germany.
    Curran D; Van Oorschot D; Varghese L; Oostvogels L; Mrkvan T; Colindres R; von Krempelhuber A; Anastassopoulou A
    Hum Vaccin Immunother; 2017 Oct; 13(10):2213-2221. PubMed ID: 28708959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends and disparity in zoster vaccine uptake in a managed care population.
    Hechter RC; Tartof SY; Jacobsen SJ; Smith N; Tseng HF
    Vaccine; 2013 Sep; 31(41):4564-8. PubMed ID: 23928461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands.
    de Boer PT; Pouwels KB; Cox JM; Hak E; Wilschut JC; Postma MJ
    Vaccine; 2013 Feb; 31(9):1276-83. PubMed ID: 23306360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and economic impact of herpes zoster vaccination in elderly in Italy.
    Boccalini S; Alicino C; Martinelli D; Bechini A; Tiscione E; Pellizzari B; Prato R; Icardi G; Iannazzo S; Bonanni P
    Hum Vaccin Immunother; 2017 Feb; 13(2):405-411. PubMed ID: 27925856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating Physician Attitudes and Practices Regarding Herpes Zoster Vaccination.
    Tsui E; Gillespie C; Perskin M; Zabar S; Wu M; Cohen EJ
    Cornea; 2018 Aug; 37(8):947-951. PubMed ID: 29578865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine.
    Tseng HF; Smith N; Sy LS; Jacobsen SJ
    Vaccine; 2011 May; 29(20):3628-32. PubMed ID: 21435407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving herpes zoster vaccination rates through use of a clinical pharmacist and a personal health record.
    Otsuka SH; Tayal NH; Porter K; Embi PJ; Beatty SJ
    Am J Med; 2013 Sep; 126(9):832.e1-6. PubMed ID: 23830534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.
    Lu PJ; Euler GL; Harpaz R
    Am J Prev Med; 2011 Feb; 40(2):e1-6. PubMed ID: 21238856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.